Risk of developing diabetes in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants or warfarin: A nationwide cohort study.
Huei-Kai HuangPeter Pin-Sung LiuShu-Man LinJin-Yi HsuCarol Chiung-Hui PengKashif M MunirTing-Yu WuJih-I YehChing-Hui LohChin-Ling ChenPublished in: Diabetes, obesity & metabolism (2020)
Taking an NOAC was associated with a lower risk of developing diabetes than taking warfarin in patients with AF.